Welcome to the International League Against Epilepsy

The World's preeminent association of health care professionals and scientists working toward a world where no person's life is limited by epilepsy

EEC 2022: Call for abstracts

Logo: ILAE Europe epilepsy congress. Text: 14th European Epilepsy Congress; 9-13 July 2022 | Geneva, Switzerland. www.ilae.org/eec2022

Abstract submission is open for the 14th European Epilepsy Congress, taking place on 9 – 13 July 2022! You have the opportunity to share your latest findings with the international community and be considered for an oral or poster presentation during EEC 2022.

The Scientific and Organising Committee encourages all researchers and practitioners from around the globe to contribute to the programme by submitting abstracts for poster or oral presentation at the congress. Deadline: 21 January 2022        

Submit a proposal

Latest News

Markus Schmutz in 2015; picture taken by Julia Franke
About ILAE

In Memoriam: Markus Schmutz

Markus Schmutz, a neuropharmacologist and long-time board member of the Swiss Epilepsy League and most recently of the partner and patient organization Epi-Suisse, passed away on 5 December 2021, after a long and patiently endured illness in Basel, his birthplace and place of work for…

16 December, 2021
ILAE
About ILAE

ILAE Virtual e-Forum Series

ILAE will be staging four virtual e-Forum in 2022, covering Rescue Medications (23 February 2022), Cannabinoids (second quarter 2022), Drug Interactions (third quarter 2022), and Selecting the First ASM (final quarter 2022).

9 December, 2021

View All News

Our Publications

The International League Against Epilepsy disseminates the latest original research findings and breakthroughs in the cure for epilepsy and related seizure disorders through its official peer-reviewed publications.

Upcoming Congresses

View All Upcoming Congresses

Subscribe to the ILAE Newsletter

To subscribe, please click on the button below.

Please send me information about ILAE activities and other
information of interest to the epilepsy community